FDA.reportPublic FDA data

Steglujan 15/100 Oral Tablet

RxCUI
1992832
RxNorm name
Steglujan 15/100 Oral Tablet
Display name
Steglujan 15/100 Oral Tablet
Full name
Steglujan 15/100 Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
STEGLUJANERTUGLIFLOZIN AND SITAGLIPTINMerck Sharp & Dohme LLCc2c553d8-5a9d-4366-bf53-8bdb5a876d192026-06-03Warnings, Adverse reactionsExact identifier
rxcui: 1992832

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c2c553d8-5a9d-4366-bf53-8bdb5a876d19Steglujan 15 MG / 100 MG Oral Tablet [PSN] · ertugliflozin 15 MG / sitagliptin 100 MG Oral Tablet [Steglujan] [SBD] · Steglujan 15/100 (ertugliflozin 15 MG / sitagliptin 100 MG) Oral Tablet [SY] · Steglujan 15/100 Oral Tablet [SY]423These highlights do not include all the information needed to use STEGLUJAN safely and effectively. See full prescribing information for STEGLUJAN. STEGLUJAN ® (ertugliflozin and sitagliptin) tablets, for oral use Initial U.S. Approval: 201720241220